EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size

Vincent Costalat, Tudor G Jovin iD, J F Albucher, Christophe Cognard, Hilde Henon, Nasreddine Nouri, Benjamin Gory, Sebastien Richard, Gaultier Marnat iD, Igor Sibon, Federico Di Maria, Mariam Annan und 48 weitere

New England Journal of Medicine · 09.05.2024 · 390 (18) · 1677-1689

DOI: 10.1056/nejmoa2314063 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift New England Journal of Medicine, erschienen am 09.05.2024. Verfasst von Vincent Costalat und 59 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Neuroradiology, Hôpital Gui de Chauliac, Montpellier (V.C.), the Departments of Neurology (J.F. Albucher) and Neuroradiology (…. Hauptthemen laut MEDLINE: Stroke, Thrombectomy, Thrombolytic Therapy, Infarction, Anterior Cerebral Artery. Die Arbeit wurde bisher 320-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The use of thrombectomy in patients with acute stroke and a large infarct of unrestricted size has not been well studied. METHODS: We assigned, in a 1:1 ratio, patients with proximal cerebral vessel occlusion in the anterior circulation and a large infarct (as defined by an Alberta Stroke Program Early Computed Tomographic Score of ≤5; values range from 0 to 10) detected on magnetic resonance imaging or computed tomography within 6.5 hours after symptom onset to undergo endovascular thrombectomy and receive medical care (thrombectomy group) or to receive medical care alone (control group). The primary outcome was the score on the modified Rankin scale at 90 days (scores range from 0 to 6, with higher scores indicating greater disability). The primary safety outcome was death from any cause at 90 days, and an ancillary safety outcome was symptomatic intracerebral hemorrhage. RESULTS: A total of 333 patients were assigned to either the thrombectomy group (166 patients) or the control group (167 patients); 9 were excluded from the analysis because of consent withdrawal or legal reasons. The trial was stopped early because results of similar trials favored thrombectomy. Approximately 35% of the patients received thrombolysis therapy. The median modified Rankin scale score at 90 days was 4 in the thrombectomy group and 6 in the control group (generalized odds ratio, 1.63; 95% confidence interval [CI], 1.29 to 2.06; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeThrombectomyThrombolytic TherapyInfarction, Anterior Cerebral ArteryAgedAged, 80 and overFemaleHumansMaleCerebral HemorrhageCombined Modality TherapyEndovascular ProceduresMagnetic Resonance ImagingTomography, X-Ray ComputedBrain InfarctionAcute DiseaseCerebral ArteriesCerebral Arterial Diseases

Autor:innen und Institutionen

  • From the Department of Neuroradiology, Hôpital Gui de Chauliac, Montpellier (V.C.), the Departments of Neurology (J.F. Albucher) and Neuroradiology (C. Cognard), Hôpital Pierre Paul Riquet, and Toulouse Clinical Investi…

ORCID-Profile: Tudor G Jovin, Gaultier Marnat, Mikael Mazighi

Zitieren

APA

Costalat, V., Jovin, T. G., Albucher, J. F., Cognard, C., Henon, H., Nouri, N., Gory, B., Richard, S., Marnat, G., Sibon, I., Di Maria, F., Annan, M., Boulouis, G., Cardona, P., Obadia, M., Piotin, M., Bourcier, R., Guillon, B., Godard, S., …, & Arquizan, C. (2024). Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size. New England Journal of Medicine, 390(18), 1677-1689. https://doi.org/10.1056/nejmoa2314063

Vancouver

Costalat V, Jovin TG, Albucher JF, Cognard C, Henon H, Nouri N, et al. Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size. New England Journal of Medicine. 2024;390(18):1677-1689. doi:10.1056/nejmoa2314063

BibTeX
@article{Costalat2024,
  author = {Costalat, Vincent and Jovin, Tudor G and Albucher, J F and Cognard, Christophe and Henon, Hilde and Nouri, Nasreddine and Gory, Benjamin and Richard, Sebastien and Marnat, Gaultier and Sibon, Igor and Di Maria, Federico and Annan, Mariam and Boulouis, Grégoire and Cardona, Pere and Obadia, Michael and Piotin, Michel and Bourcier, Romain and Guillon, Benoit and Godard, Sophie and Pasco-Papon, Anne and Eker, Omer F and Cho, Tae-Hee and Turc, Guillaume and Naggara, Olivier and Velasco, Stéphane and Lamy, Matthias and Clarençon, Frédéric and Alamowitch, Sonia and Renu, Arturo and Suissa, Laurent and Brunel, Hervé and Gentric, Jean-Christophe and Timsit, Serge and Lamy, Chantal and Chivot, Cyril and Macian-Montoro, Francisco and Mounayer, Charbel and Ozkul-Wermester, Ozlem and Papagiannaki, Chrysanthi and Wolff, Valérie and Pop, Raoul and Ferrier, Anna and Chabert, Emmanuel and Ricolfi, Frédéric and Béjot, Yannick and Lopez-Cancio, Elena and Vega, Pedro and Spelle, Laurent and Denier, Christian and Millán, Mònica and Arenillas, Juan F and Mazighi, Mikael and Houdart, Emmanuel and Del Mar Freijo, Maria and Duhamel, Alain and Sanossian, Nerses and Liebeskind, David S and Labreuche, Julien and Lapergue, Bertrand and Arquizan, Caroline},
  title = {Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {18},
  pages = {1677--1689},
  doi = {10.1056/nejmoa2314063}
}
Kostenlos starten →